Literature DB >> 26546502

Steroidal saponins from stems and leaves of Paris polyphylla var. yunnanensis.

Xu-Jie Qin1, Mu-Yuan Yu1, Wei Ni2, Huan Yan2, Chang-Xiang Chen2, Yung-Chi Cheng3, Li He4, Hai-Yang Liu5.   

Abstract

Phytochemical investigation of the stems and leaves of Paris polyphylla var. yunnanensis led to isolation of 12 steroidal saponins, chonglouosides SL-9-SL-20, which had not been described previously, along with 13 known compounds. Their structures were established on the basis of extensive spectroscopic analysis and chemical methods. Four of the twelve steroidal saponins possessed three steroidal aglycones which have not been reported in nature. Steroidal saponins were also evaluated for their cytotoxicities against two human cancer cell lines (HepG2 and HEK293) and anti-HCV effects. One known steroidal saponin was the most cytotoxic compound overall with IC50 values of 2.9 ± 0.5 μM and 5.0 ± 0.6 μM against HepG2 and HEK293 cell lines, respectively, while none showed anti-HCV activity at a concentration of 20 μM.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anti-HCV activity; Chonglouosides SL-9–SL-20; Cytotoxicity; Paris polyphylla var. yunnanensis; Steroidal saponins; Trilliaceae

Mesh:

Substances:

Year:  2015        PMID: 26546502     DOI: 10.1016/j.phytochem.2015.10.008

Source DB:  PubMed          Journal:  Phytochemistry        ISSN: 0031-9422            Impact factor:   4.004


  10 in total

1.  Study of Chemical Compositions and Anticancer Effects of Paris polyphylla var. Chinensis Leaves.

Authors:  Feng Su; Lv Ye; Zilin Zhou; An Su; Jinping Gu; Zili Guo; Peixi Zhu; Weike Su
Journal:  Molecules       Date:  2022-04-23       Impact factor: 4.927

2.  A Potential Biofertilizer-Siderophilic Bacteria Isolated From the Rhizosphere of Paris polyphylla var. yunnanensis.

Authors:  Yihan Wang; Gongyou Zhang; Ya Huang; Min Guo; Juhui Song; Tingting Zhang; Yaohang Long; Bing Wang; Hongmei Liu
Journal:  Front Microbiol       Date:  2022-05-09       Impact factor: 6.064

Review 3.  Untiring Researches for Alternative Resources of Rhizoma Paridis.

Authors:  Xu-Jie Qin; Wei Ni; Chang-Xiang Chen; Hai-Yang Liu
Journal:  Nat Prod Bioprospect       Date:  2018-07-04

4.  Antibacterial, Antifungal, Antiviral, and Anthelmintic Activities of Medicinal Plants of Nepal Selected Based on Ethnobotanical Evidence.

Authors:  Bishnu Joshi; Sujogya Kumar Panda; Ramin Saleh Jouneghani; Maoxuan Liu; Niranjan Parajuli; Pieter Leyssen; Johan Neyts; Walter Luyten
Journal:  Evid Based Complement Alternat Med       Date:  2020-04-22       Impact factor: 2.629

5.  Capturing the Geoherbalism Differentiation in Wild Paris polyphylla var. yunnanensis Raw Materials through the Application of Multispectral Information Fusion Combined with Chemometrics.

Authors:  Yuanzhong Wang; Yan Li; Jinyu Zhang
Journal:  ACS Omega       Date:  2019-11-01

6.  RNA-Seq analysis reveals the important co-expressed genes associated with polyphyllin biosynthesis during the developmental stages of Paris polyphylla.

Authors:  Xiaoyang Gao; Qixuan Su; Jing Li; Wenjing Yang; Baolin Yao; Jiawei Guo; Shengying Li; Changning Liu
Journal:  BMC Genomics       Date:  2022-08-05       Impact factor: 4.547

Review 7.  Recent advances in steroidal saponins biosynthesis and in vitro production.

Authors:  Swati Upadhyay; Gajendra Singh Jeena; Rakesh Kumar Shukla
Journal:  Planta       Date:  2018-05-10       Impact factor: 4.116

8.  Two New Highly Oxygenated Spirostanol Saponins from Paris polyphylla var. stenophylla.

Authors:  Ling-Yu Jin; Ting-Xiang Lu; Xu-Jie Qin; Wei Ni; Huan Yan; Yu Chen; Hui Liu; Hong-Ping He; Hai-Yang Liu
Journal:  Nat Prod Bioprospect       Date:  2016-06-02

9.  Bacterial Diversity in Roots, Stems, and Leaves of Chinese Medicinal Plant Paris polyphylla var. yunnanensis.

Authors:  Tian-Hao Liu; Yin Zhou; Wen-Cong Tao; Yang Liu; Xiao-Mei Zhang; Shou-Zheng Tian
Journal:  Pol J Microbiol       Date:  2020-03-11

10.  Saponins From Paris forrestii (Takht.) H. Li Display Potent Activity Against Acute Myeloid Leukemia by Suppressing the RNF6/AKT/mTOR Signaling Pathway.

Authors:  Qin Lu; Yuanming He; Yuehu Wang; Li Gao; Yunjing Zheng; Zubin Zhang; Biyin Cao; Qi Wang; Xinliang Mao; Shaoyan Hu
Journal:  Front Pharmacol       Date:  2018-06-26       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.